subject: Aarkstore Enterprise -- International Stem Cell Corporation (isco) - Financial And Strategic Analysi [print this page] Aarkstore announce a new report " International Stem Cell Corporation (ISCO) - Financial and Strategic Analysis Review" through its vast collection of market research report.
International Stem Cell Corporation (International Stem Cell) is a publicly held biotechnology company. It is focused on developing therapeutic products and research products. The company creates human cells for the treatment corneal disease, diabetes, liver disease, and retinal disease through cell transplant therapy. International Stem Cell develops pluripotent stem cells that are comparable in function to embryonic stem cells from which cells for human transplant are derived; and techniques to cause those cells to be differentiated into the specific cell types required for transplant, as well as manufactures protocols to produce these cells without contamination with animal by-products.
International Stem Cell Corporation Key Recent Developments
Mar 18, 2010: ISCO Begins Second Pre-Clinical Phase Of Testing RPE For Treatment Of Retinal Diseases
Feb 04, 2010: ISCO Opens Facility For Production Of Clinical-Grade Stem Cell Products
Feb 04, 2010: International Stem Cell Opens California Cell Production Facility
Oct 13, 2009: Lifeline Cell Technology Launches New Products Into Human Cell Research Market
This comprehensive SWOT profile of International Stem Cell Corporation provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of International Stem Cell Corporation, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
